Oligonucleotides capable o
f sequence-speci
fic triple helix
formation have been proposed asDNA binding ligands use
ful
for modulation o
f gene expression and
for directed genome modi
fication.However, the e
ffectiveness o
f such triplex-
forming oligonucleotides (TFOs) depends on their ability
tobind to their target sites within cells, and this can be limited under physiologic conditions. In particular,triplex
formation in the pyrimidine moti
f is
favored by unphysiologically low pH and high magnesiumconcentrations. To address these limitations, a series o
f pyrimidine TFOs were tested
for third-strandbinding under a variety o
f conditions. Those containing 5-(1-propynyl)-2'-deoxyuridine (pdU) and 5-methyl-2'-deoxycytidine (5meC) showed superior binding characteristics at neutral pH and at low magnesiumconcentrations, as determined by gel mobility shi
ft assays and thermal dissociation pro
files. Over a rangeo
f Mg
2+ concentrations, pdU-modi
fied TFOs
formed more stable triplexes than did TFOs containing2'-deoxythymidine. At 1 mM Mg
2+, a
![](/images/gi<font color=)
fchars/Delta.gi
f" BORDER=0 >Tm o
f 30
![](/images/entities/deg.gi<font color=)
f">C was observed
for pdU- versus T-containing 15-mers (o
f generic sequence 5' TTTTCTTTTTTCTTTTCT 3') binding to the cognate A:T bp rich site,indicating that pdU-containing TFOs are capable o
f substantial binding even at physiologically low Mg
2+concentrations. In addition, the pdU-containing TFOs were superior in gene targeting experiments inmammalian cells, yielding 4-
fold higher mutation
frequencies in a shuttle vector-based mutagenesis assaydesigned to detect mutations induced by third-strand-directed psoralen adducts. These results suggest theutility o
f the pdU substitution in the pyrimidine moti
f for triplex-based gene targeting experiments.